INDIANAPOLIS — An Indiana University School of Medicine researcher is working with the Mayo Clinic on a study looking at blood biomarkers and Alzheimer’s disease.
Dr. Jeffrey Dage's previous studies have demonstrated that blood levels of phosphorylated tau (P-tau) are indicators of the development of Alzheimer’s disease pathology in the brain.
READ: Study from Dr. Dage and others
Blood-based biomarkers are the goal in screening for and diagnosing Alzheimer’s disease in the population because they are less costly and invasive than imaging and a lumbar puncture, Dage and Dr. Michelle Mielke with the Mayo Clinic said.
The IU School of Medicine says there are multiple ways for Hoosiers to get involved in the research, including donating blood to the Indiana Biobank or by completing a participant referral form.
Additionally, some Indiana patients will receive new screenings for early detection of Alzheimer’s disease thanks to a pilot program.
The program provides a digital cognitive assessment tool to screen patients for Alzheimer’s and electronically check brain function. Currently, those screenings are not part of normal primary care visits.
The Core Cognitive Evaluation is completely iPad-based and combines a digital assessment with a lifestyle-based patient questionnaire to generate actionable insights for both providers and patients.
-
Buds, blooms, and wildflowers: Indiana's first signs of spring are showing
Greenfield native carries UConn to Final Four with game-winning three-pointer
Mullins graduated from Greenfield Central High School in 2025 and became the school’s first-ever and only Indiana Mr. Basketball.
Greenfield native carries UConn to Final Four with game-winning three-pointer
Carmel construction workers preach caution amid project ramp-ups
While construction can be frustrating for drivers, it can be dangerous for those doing the work when drivers do not slow down, stay off their phones, and move over.
